☰

Charles Arntzen - Publications

Affiliations: 
University of Illinois, Urbana-Champaign, Urbana-Champaign, IL 
Tree Info Similar researchers PubMed Report error

26 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Arntzen C. Plant-made pharmaceuticals: from 'Edible Vaccines' to Ebola therapeutics. Plant Biotechnology Journal. 13: 1013-6. PMID 26345276 DOI: 10.1111/Pbi.12460  0.392
2011 Phoolcharoen W, Dye JM, Kilbourne J, Piensook K, Pratt WD, Arntzen CJ, Chen Q, Mason HS, Herbst-Kralovetz MM. A nonreplicating subunit vaccine protects mice against lethal Ebola virus challenge. Proceedings of the National Academy of Sciences of the United States of America. 108: 20695-700. PMID 22143779 DOI: 10.1073/Pnas.1117715108  0.689
2011 Velasquez LS, Shira S, Berta AN, Kilbourne J, Medi BM, Tizard I, Ni Y, Arntzen CJ, Herbst-Kralovetz MM. Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine. Vaccine. 29: 5221-31. PMID 21640778 DOI: 10.1016/J.Vaccine.2011.05.027  0.442
2011 Phoolcharoen W, Bhoo SH, Lai H, Ma J, Arntzen CJ, Chen Q, Mason HS. Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnology Journal. 9: 807-16. PMID 21281425 DOI: 10.1111/J.1467-7652.2011.00593.X  0.715
2010 Velasquez LS, Hjelm BE, Arntzen CJ, Herbst-Kralovetz MM. An intranasally delivered Toll-like receptor 7 agonist elicits robust systemic and mucosal responses to Norwalk virus-like particles. Clinical and Vaccine Immunology : Cvi. 17: 1850-8. PMID 20962211 DOI: 10.1128/Cvi.00230-10  0.389
2010 Huang Z, Phoolcharoen W, Lai H, Piensook K, Cardineau G, Zeitlin L, Whaley KJ, Arntzen CJ, Mason HS, Chen Q. High-level rapid production of full-size monoclonal antibodies in plants by a single-vector DNA replicon system. Biotechnology and Bioengineering. 106: 9-17. PMID 20047189 DOI: 10.1002/Bit.22652  0.687
2009 Huang Z, Chen Q, Hjelm B, Arntzen C, Mason H. A DNA replicon system for rapid high-level production of virus-like particles in plants. Biotechnology and Bioengineering. 103: 706-14. PMID 19309755 DOI: 10.1002/Bit.22299  0.754
2008 Santi L, Batchelor L, Huang Z, Hjelm B, Kilbourne J, Arntzen CJ, Chen Q, Mason HS. An efficient plant viral expression system generating orally immunogenic Norwalk virus-like particles. Vaccine. 26: 1846-54. PMID 18325641 DOI: 10.1016/J.Vaccine.2008.01.053  0.699
2007 Kim TG, Kim MY, Kim BG, Kang TJ, Kim YS, Jang YS, Arntzen CJ, Yang MS. Synthesis and assembly of Escherichia coli heat-labile enterotoxin B subunit in transgenic lettuce (Lactuca sativa). Protein Expression and Purification. 51: 22-7. PMID 16919472 DOI: 10.1016/j.pep.2006.05.024  0.484
2006 Lee KY, Kim DH, Kang TJ, Kim J, Chung GH, Yoo HS, Arntzen CJ, Yang MS, Jang YS. Induction of protective immune responses against the challenge of Actinobacillus pleuropneumoniae by the oral administration of transgenic tobacco plant expressing ApxIIA toxin from the bacteria. Fems Immunology and Medical Microbiology. 48: 381-9. PMID 17054716 DOI: 10.1111/j.1574-695X.2006.00158.x  0.535
2006 van der Laan JW, Minor P, Mahoney R, Arntzen C, Shin J, Wood D. WHO informal consultation on scientific basis for regulatory evaluation of candidate human vaccines from plants, Geneva, Switzerland, 24-25 January 2005. Vaccine. 24: 4271-8. PMID 16767805 DOI: 10.1016/J.Vaccine.2005.12.063  0.573
2006 Saldaña S, Esquivel Guadarrama F, Olivera Flores Tde J, Arias N, López S, Arias C, Ruiz-Medrano R, Mason H, Mor T, Richter L, Arntzen CJ, Gómez Lim MA. Production of rotavirus-like particles in tomato (Lycopersicon esculentum L.) fruit by expression of capsid proteins VP2 and VP6 and immunological studies. Viral Immunology. 19: 42-53. PMID 16553549 DOI: 10.1089/Vim.2006.19.42  0.739
2006 Huang Z, Santi L, LePore K, Kilbourne J, Arntzen CJ, Mason HS. Rapid, high-level production of hepatitis B core antigen in plant leaf and its immunogenicity in mice. Vaccine. 24: 2506-13. PMID 16417953 DOI: 10.1016/J.Vaccine.2005.12.024  0.718
2006 Santi L, Giritch A, Roy CJ, Marillonnet S, Klimyuk V, Gleba Y, Webb R, Arntzen CJ, Mason HS. Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system. Proceedings of the National Academy of Sciences of the United States of America. 103: 861-6. PMID 16410352 DOI: 10.1073/Pnas.0510014103  0.703
2005 Maloney BJ, Takeda N, Suzaki Y, Ami Y, Li TC, Miyamura T, Arntzen CJ, Mason HS. Challenges in creating a vaccine to prevent hepatitis E. Vaccine. 23: 1870-4. PMID 15734058 DOI: 10.1016/J.Vaccine.2004.11.020  0.725
2005 Huang Z, Elkin G, Maloney BJ, Beuhner N, Arntzen CJ, Thanavala Y, Mason HS. Virus-like particle expression and assembly in plants: hepatitis B and Norwalk viruses. Vaccine. 23: 1851-8. PMID 15734055 DOI: 10.1016/J.Vaccine.2004.11.017  0.743
2005 Arntzen C, Plotkin S, Dodet B. Plant-derived vaccines and antibodies: potential and limitations. Vaccine. 23: 1753-6. PMID 15734036 DOI: 10.1016/J.Vaccine.2005.01.090  0.596
2005 Thanavala Y, Mahoney M, Pal S, Scott A, Richter L, Natarajan N, Goodwin P, Arntzen CJ, Mason HS. Immunogenicity in humans of an edible vaccine for hepatitis B. Proceedings of the National Academy of Sciences of the United States of America. 102: 3378-82. PMID 15728371 DOI: 10.1073/Pnas.0409899102  0.686
2004 Matoba N, Magérus A, Geyer BC, Zhang Y, Muralidharan M, Alfsen A, Arntzen CJ, Bomsel M, Mor TS. A mucosally targeted subunit vaccine candidate eliciting HIV-1 transcytosis-blocking Abs. Proceedings of the National Academy of Sciences of the United States of America. 101: 13584-9. PMID 15347807 DOI: 10.1073/Pnas.0405297101  0.411
2004 Peterson RK, Arntzen CJ. On risk and plant-based biopharmaceuticals. Trends in Biotechnology. 22: 64-6. PMID 14757039 DOI: 10.1016/j.tibtech.2003.11.007  0.356
2003 Smith ML, Richter L, Arntzen CJ, Shuler ML, Mason HS. Structural characterization of plant-derived hepatitis B surface antigen employed in oral immunization studies. Vaccine. 21: 4011-21. PMID 12922138 DOI: 10.1016/S0264-410X(03)00268-8  0.745
2003 Walmsley AM, Arntzen CJ. Plant cell factories and mucosal vaccines. Current Opinion in Biotechnology. 14: 145-50. PMID 12732315 DOI: 10.1016/s0958-1669(03)00026-0  0.573
2003 Rigano MM, Sala F, Arntzen CJ, Walmsley AM. Targeting of plant-derived vaccine antigens to immunoresponsive mucosal sites. Vaccine. 21: 809-11. PMID 12531365 DOI: 10.1016/s0264-410x(02)00604-7  0.518
2002 Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends in Molecular Medicine. 8: 324-9. PMID 12114111 DOI: 10.1016/S1471-4914(02)02360-2  0.744
1995 Thanavala Y, Yang YF, Lyons P, Mason HS, Arntzen C. Immunogenicity of transgenic plant-derived hepatitis B surface antigen. Proceedings of the National Academy of Sciences of the United States of America. 92: 3358-3361. PMID 7724566 DOI: 10.1073/Pnas.92.8.3358  0.704
1992 Huttner SL, Arntzen C, Beachy R, Breuning G, Nester E, Qualset C, Vidaver A. Revising Oversight of Genetically Modified Plants Nature Biotechnology. 10: 967-971. DOI: 10.1038/Nbt0992-967  0.384
Show low-probability matches.